AIMC Journal:
Neuropsychopharmacology reports

Showing 1 to 3 of 3 articles

Digital and Biomarker-Based Monitoring for Schizophrenia-Treatment Adherence.

Neuropsychopharmacology reports
BACKGROUND: Nonadherence to antipsychotics affects nearly half of patients with schizophrenia, leading to rehospitalization, suicidality, and reduced quality of life. Optimizing treatment adherence is critical to prevent disease relapses, which can b...

Pharmacological Incongruity of Lacosamide in the Management of Delirium Complicated by Ileus.

Neuropsychopharmacology reports
Delirium involves neurotransmitter imbalances and disrupted neural networks. Although lacosamide may theoretically treat delirium by reducing neuronal hyperexcitability via sodium channel modulation, clinical evidence is lacking. Sodium channels in t...

A Preliminary Open-Label Pilot Study of a Pillow-Based ELF-ELME (Extremely Low-Frequency, Extremely Low Magnetic Environment) Intervention for Major Depressive Disorder.

Neuropsychopharmacology reports
BACKGROUND: Mitochondrial dysfunction has been implicated in the pathogenesis of depression. Major depressive disorder (MDD) is a prevalent condition with substantial individual and societal burden. A novel approach-exposure to an extremely low-frequ...